These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 24347663

  • 1. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
    van Deursen VM, Damman K, Voors AA, van der Wal MH, Jaarsma T, van Veldhuisen DJ, Hillege HL.
    Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A, Ruocco G, Pellegrini M, De Gori C, Del Castillo G, Franci B, Nuti R, Ronco C.
    Am J Cardiol; 2015 Jul 01; 116(1):104-11. PubMed ID: 25943992
    [Abstract] [Full Text] [Related]

  • 3. Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure.
    Elsharawy S, Raslan L, Morsy S, Hassan B, Khalifa N.
    Saudi J Kidney Dis Transpl; 2016 Jan 01; 27(1):49-54. PubMed ID: 26787566
    [Abstract] [Full Text] [Related]

  • 4. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
    Lim WH, Lewis JR, Wong G, Teo R, Lim EM, Byrnes E, Prince RL.
    Am J Nephrol; 2015 Jan 01; 41(2):156-64. PubMed ID: 25824561
    [Abstract] [Full Text] [Related]

  • 5. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
    Palazzuoli A, Ruocco G, Beltrami M, Franci B, Pellegrini M, Lucani B, Nuti R, Ronco C.
    Acute Card Care; 2014 Sep 01; 16(3):93-101. PubMed ID: 24836558
    [Abstract] [Full Text] [Related]

  • 6. Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement.
    Pronschinske KB, Qiu S, Wu C, Kato TS, Khawaja T, Takayama H, Naka Y, Templeton DL, George I, Farr MA, Mancini DM, Schulze PC.
    J Heart Lung Transplant; 2014 Dec 01; 33(12):1215-22. PubMed ID: 25049066
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U, Bachorzewska-Gajewska H, Malyszko J, Dobrzycki S.
    Adv Med Sci; 2013 Dec 01; 58(2):353-61. PubMed ID: 24384771
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft recipients.
    Przybylowski P, Malyszko J, Malyszko J.
    Med Sci Monit; 2010 Sep 01; 16(9):CR440-4. PubMed ID: 20802417
    [Abstract] [Full Text] [Related]

  • 15. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension.
    Gharishvandi F, Kazerouni F, Ghanei E, Rahimipour A, Nasiri M.
    Iran Biomed J; 2015 Sep 01; 19(2):76-81. PubMed ID: 25864811
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure.
    Alvelos M, Lourenço P, Dias C, Amorim M, Rema J, Leite AB, Guimarães JT, Almeida P, Bettencourt P.
    Int J Cardiol; 2013 Apr 30; 165(1):51-5. PubMed ID: 21872946
    [Abstract] [Full Text] [Related]

  • 17. Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment.
    Emans ME, Braam B, Diepenbroek A, van der Putten K, Cramer MJ, Wielders JP, Swinkels DW, Doevendans PA, Gaillard CA.
    Kidney Blood Press Res; 2012 Apr 30; 36(1):344-54. PubMed ID: 23235391
    [Abstract] [Full Text] [Related]

  • 18. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
    Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Pawlak K, Dobrzycki S.
    Nephrology (Carlton); 2008 Apr 30; 13(2):153-6. PubMed ID: 18275504
    [Abstract] [Full Text] [Related]

  • 19. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study.
    Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Dragun D, Haase M.
    Crit Care Med; 2009 Feb 30; 37(2):553-60. PubMed ID: 19114878
    [Abstract] [Full Text] [Related]

  • 20. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Alharazy SM, Kong N, Saidin R, Gafor AH, Maskon O, Mohd M, Zakaria SZ.
    Angiology; 2014 May 30; 65(5):436-42. PubMed ID: 23580616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.